Kinetic and pH studies on human phenylethanolamine N-methyltransferase

Area of Science:

• Biochemistry
• Enzymology
• Pharmacology

Background:

• Phenylethanolamine N-methyltransferase (PNMT) catalyzes the final step in catecholamine biosynthesis, converting norepinephrine to epinephrine.
• PNMT inhibitors are explored as potential antihypertensive agents.
• The kinetic mechanism of PNMT has been previously debated, with proposed random, ordered (norepinephrine first), and ordered (AdoMet first) models.

Purpose of the Study:

• To elucidate the kinetic mechanism of human PNMT.
• To investigate the substrate binding order and catalytic requirements of hPNMT.

Main Methods:

• Initial velocity studies in the presence and absence of inhibitors.
• Isothermal titration calorimetry (ITC).
• Fluorescence binding experiments.
• pH-profile analysis of kinetic parameters and inhibitor binding.

Main Results:

• Human PNMT operates via an ordered sequential mechanism, with S-adenosyl-L-methionine (AdoMet) binding prior to phenylethanolamine.
• pH-dependent kinetic studies revealed bell-shaped profiles, indicating the involvement of both protonated and unprotonated catalytic groups.
• The inhibitor SK&F 29661 binding also showed pH-dependent behavior consistent with catalytic group requirements.

Conclusions:

• The binding of AdoMet first is essential for the catalytic activity of human PNMT.
• Catalysis by hPNMT requires specific protonation states of key amino acid residues.
• Understanding the precise kinetic mechanism and catalytic requirements can inform the design of more effective PNMT inhibitors for therapeutic applications.